Concepedia

Author

J.-F. Bosset

Centre Hospitalier Universitaire de Besançon

Also Known As

Bosset, Jean-Bernard, J Bosset, J F Bosset, J. -F. Bosset, J. Bosset, J. F. Bosset, J.-F. Bosset, J.F Bosset, J.F. Bosset, Jean‐Franois Bosset

96

Publications

2.5K

Citations

17

H-Index

36

Concepts

All Affiliations

Centre Hospitalier Universitaire de BesançonEuropean Organisation for Research and Treatment of CancerCentre Georges François LeclercUniversitair Ziekenhuis LeuvenCentre Hospitalier Universitaire de Grenoble
JB

About

J.-F. Bosset is an author at Centre Hospitalier Universitaire de Besançon specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

1.3K

2

Health Sciences

6

6

1.1K

3

Diagnostic Sciences

1

1

49

4

Gastroenterology

1

1

60

5

Pathology

1

1

60

J.-F. Bosset

×

14

Publications

2.2K

Citations

14

H-Index

YearCitations

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.

Aimery de Gramont, J.-F. Bosset, C Milan,

Journal of Clinical Oncology

1997

904

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Bruno Chauffert, F. Mornex, F. Bonnetain,

Annals of Oncology

2008

685

Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance

J.-F. Bosset, G. Calais, A. Daban,

European Journal of Cancer

2003

177

Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: Results of three consecutive phase II studies

J.-F. Bosset, J.J. Pavy, Han Hamers,

European Journal of Cancer

1993

82

Preoperative radiation (Preop RT) in rectal cancer: Effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial

J.-F. Bosset, G. Calais, Laurent Mineur,

Journal of Clinical Oncology

2005

71

Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995–2002

Jean Faivre, Annalisa Trama, Roberta De Angelis,

European Journal of Cancer

2011

60

Phase III trial comparing initial chemoradiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: A FFCD-SFRO study

Bruno Chauffert, F. Mornex, Franck Bonnetain,

Journal of Clinical Oncology

2006

55

Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study

J.-F. Bosset, J.J. Pavy, M Gillet,

Radiotherapy and Oncology

1992

52

Postoperative Radiotherapy After Radical Prostatectomy: A Randomised Controlled Trial (EORTC Trial 22911)

M. Bolla, Hendrik Van Poppel, Laurence Collette,

The Journal of Urology

2006

49

Does the addition of chemotherapy (CT) to preoperative radiotherapy (preopRT) increase the pathological response in patients with resected rectal cancer : Report of the 22921 EORTC phase III trial

J.-F. Bosset, G. Calais, Laurent Mineur,

Journal of Clinical Oncology

2004

31

Page 1